STORZ MEDICAL’s MAGNETOLITH receives CE approval

2020-02-24_001_news

In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.

Continua a leggere
2
  4307 Visite
  0 Commenti
4307 Visite
0 Commenti
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel